BARRX is a new treatment option for Barrett’s Esophagus, a condition that can often result from chronic heartburn or Gastroesophageal Reflux Disease, commonly referred to as GERD. It is performed by St.Vincent Salem Hospital Gastroenterologist, Jeffrey Morgan, MD in conjunction with an upper endoscopy and does not require any incisions or surgery. BARRX can minimize the risk of developing esophageal cancer if suffering from Barrett’s Esophagus.
Reasons for the ExamBarrett's esophagus is the name given to describe abnormal tissue in the esophagus which can occur as a result of gastro-esophageal reflux (GERD). These abnormal cells can become cancerous. The procedure of ablating or removing cells can prevent the tissue from developing into a cancer. The abnormal cells are destroyed and new healthy cells replace them.
The ProcedureUpper Endoscopy is usually performed on an outpatient basis. It is performed with the patient lying on the left side. For the procedure you will swallow a thin, flexible, lighted tub called an endoscope. The endoscope transmits an image of the inside of the esophagus. The physician will view the esophagus with the endoscope and measure the area that requires treatment. The physician will then insert a BARRX ablation catheter into the esophagus to deliver energy to only the abnormal tissue.
BenefitsThis procedure can minimize or prevent abnormal cells from developing into a cancerous condition of the esophagus.
SummaryBARRX can minimize your risk of developing esophageal cancer if you suffer from Barrett's Esophagus. It is extremely important that you continue with your treatment for GERD on a long term basis as advised by your physician to prevent further damage to the lining of the esophagus.
TIF was developed to emulate more invasive surgical techniques, but from within and completely without incisions and visible scars.
The EsophyX TIF device is completely incisionless and is performed through the mouth, rather than through an abdominal incision. Typically, the procedure lasts no more than 30-45 minutes and is performed under general anesthesia. The procedure reconstructs the antireflux barrier beween the stomach and the esophagus to restore the competency of the gastroesophageal junction. Most patients can go home the next day and return to work within a few days.
In clinical studies, 79% of patients undergoing TIF remained off daily medications such as Nexium and Prilosec and 70% experienced a total elimination of the heartburn at five years after incisionless surgery. Patients undergoing the TIF reserve the possibility of future surgical options and revisions if they have a relapse of symptoms.
For More Information Visit: